• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. CLEARVUE INFUSAPORT; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. CLEARVUE INFUSAPORT; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR Back to Search Results
Model Number 1608062
Device Problem Patient Device Interaction Problem (4001)
Patient Problem Pleural Effusion (2010)
Event Date 10/21/2022
Event Type  malfunction  
Event Description
Suspected pleural effusion from chemotherapy access.Fda safety report id #(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLEARVUE INFUSAPORT
Type of Device
PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR
Manufacturer (Section D)
C.R. BARD, INC.
MDR Report Key15744108
MDR Text Key303335345
Report NumberMW5113092
Device Sequence Number1
Product Code LJT
UDI-Device Identifier00801741026430
UDI-Public00801741026430
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Risk Manager
Type of Report Initial
Report Date 11/02/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/31/2023
Device Model Number1608062
Device Catalogue Number1608062
Device Lot NumberREGT1276
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received11/04/2022
Patient Sequence Number1
Patient Age77 YR
Patient SexFemale
Patient Weight62 KG
-
-